Ghent University Academic Bibliography

Your filters: cql: author="Vergote, Ignace" or (type any "bookEditor issueEditor" and editor="Vergote, Ignace")

Add to list
- Journal Article
- A1
- open access
Use of individualized starting dose and niraparib hematologic adverse event management costs in ovarian cancer

Whitney S Graybill, Ignace Vergote, Bhavana Pothuri, Maarit Anttila, David M O'Malley, Domenica Lorusso, Ashley F Haggerty, Michel Fabbro, John K Chan, Florian Heitz, et al.

(2025) JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH. 14(1).
Add to list
- Journal Article
- A1
- open access
Tumor Treating Fields therapy in platinum-resistant ovarian cancer : results of the ENGOT-ov50/GOG-3029/INNOVATE-3 pivotal phase 3 randomized study

Ignace Vergote, Larry J. Copeland, Toon Van Gorp, Annouschka Laenen, Giovanni Scambia, Premal H. Thaker, David Cibula, Nicoletta Colombo, Jayanthi Lea, Antonio Gonzalez-Martin, et al.

(2025) EUROPEAN JOURNAL OF CANCER. 219.
Add to list
- Miscellaneous
- open access
Beyond BRCA deficiency : clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma

Dale Garsed, Tibor Zwimpfer, Sian Fereday, Ahwan Pandey, Dinuka Ariyaratne, Madawa Jayawardana, Laura Twomey, Céline Laumont, Catherine Kennedy, Adelyn Bolithon, et al.

(2025) Research Square.
Add to list
- Journal Article
- A1
- open access
Tisotumab vedotin in combination with carboplatin, pembrolizumab, or bevacizumab in recurrent or metastatic cervical cancer : results from the innovaTV 205/GOG-3024/ENGOT-cx8 study

Ignace Vergote, Els Van Nieuwenhuysen, Roisin E. O'Cearbhaill, Anneke Westermann, Domenica Lorusso, Sharad Ghamande, Dearbhaile C. Collins, Susana Banerjee, Cara A. Mathews, Christine Gennigens, et al.

(2023) JOURNAL OF CLINICAL ONCOLOGY. 41(36). p.5536-5549
Add to list
- Journal Article
- A1
- open access
CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma : an ovarian tumor tissue analysis consortium study

Eun-Young Kang, Ashley Weir, Nicola S Meagher, Kyo Farrington, Gregg S Nelson, Prafull Ghatage, Cheng-Han Lee, Marjorie J Riggan, Adelyn Bolithon, Gordana Popovic, et al.

(2023) CANCER. 129(5). p.697-713
Add to list
- Journal Article
- A1
- open access
Atezolizumab combined with bevacizumab and platinum-based therapy for platinum-sensitive ovarian cancer : placebo-controlled randomized phase III ATALANTE/ENGOT-ov29 trial

Jean-Emmanuel Kurtz, Eric Pujade-Lauraine, Ana Oaknin, Lisa Belin, Katharina Leitner, David Cibula, Hannelore Denys (UGent) , Ora Rosengarten, Manuel Rodrigues, Nikolaus de Gregorio, et al.

(2023) JOURNAL OF CLINICAL ONCOLOGY. 41(30). p.4768-4778
Add to list
- Journal Article
- A1
Randomized CLIO/BGOG-ov10 trial of olaparib monotherapy versus physician's choice chemotherapy in relapsed ovarian cancer

Adriaan Vanderstichele, Liselore Loverix, Pieter Busschaert, Els Van Nieuwenhuysen, Sileny N. Han, Nicole Concin, Tiene Callewaert, Siel Olbrecht, Rawand Salihi (UGent) , Patrick Berteloot, et al.

(2022) GYNECOLOGIC ONCOLOGY. 165(1). p.14-22
Add to list
Prospective non-interventional BELOVA/BGOG-ov16 study on safety of frontline bevacizumab in elderly patients with FIGO stage IV ovarian cancer : a study of the Belgian and Luxembourg Gynaecological Oncology Group

Ignace Vergote, Els Van Nieuwenhuysen, Stefanie De Waele, Christof Vulsteke, Caroline Lamot, Heidi Van den Bulck, Nele Claes, Marie-Pascale Graas, Guy Debrock, Isabelle Spoormans, et al.

(2022) INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 32(6). p.753-760
Add to list
Clear cell carcinoma of the endometrium

Giorgio Bogani, Isabelle Ray-Coquard, Nicole Concin, Natalie Y.L. Ngoi, Philippe Morice, Takayuki Enomoto, Kazuhiro Takehara, Hannelore Denys (UGent) , Domenica Lorusso, Robert Coleman, et al.

(2022) GYNECOLOGIC ONCOLOGY. 164(3). p.658-666
Add to list
- Journal Article
- A1
Experience with PlasmaJet™ in debulking surgery in 87 patients with advanced‐stage ovarian cancer

Alexander Volcke, Els Van Nieuwenhuysen, Sileny Han, Rawand Salihi (UGent) , Toon Van Gorp and Ignace Vergote

(2021) JOURNAL OF SURGICAL ONCOLOGY. 123(4). p.1109-1114

Academic Bibliography

Use of individualized starting dose and niraparib hematologic adverse event management costs in ovarian cancer

Tumor Treating Fields therapy in platinum-resistant ovarian cancer : results of the ENGOT-ov50/GOG-3029/INNOVATE-3 pivotal phase 3 randomized study

Beyond BRCA deficiency : clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma

Tisotumab vedotin in combination with carboplatin, pembrolizumab, or bevacizumab in recurrent or metastatic cervical cancer : results from the innovaTV 205/GOG-3024/ENGOT-cx8 study

CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma : an ovarian tumor tissue analysis consortium study

Atezolizumab combined with bevacizumab and platinum-based therapy for platinum-sensitive ovarian cancer : placebo-controlled randomized phase III ATALANTE/ENGOT-ov29 trial

Randomized CLIO/BGOG-ov10 trial of olaparib monotherapy versus physician's choice chemotherapy in relapsed ovarian cancer

Prospective non-interventional BELOVA/BGOG-ov16 study on safety of frontline bevacizumab in elderly patients with FIGO stage IV ovarian cancer : a study of the Belgian and Luxembourg Gynaecological Oncology Group

Clear cell carcinoma of the endometrium

Experience with PlasmaJet™ in debulking surgery in 87 patients with advanced‐stage ovarian cancer

Contents

Support

Contact